Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.63
-0.09 (-0.23%)
At close: Aug 15, 2025, 3:59 PM
38.90
0.69%
After-hours: Aug 15, 2025, 05:07 PM EDT

Cytokinetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-589.53M -526.24M -388.95M -215.31M
Depreciation & Amortization
9.53M 11.89M 5.81M 2.28M
Stock-Based Compensation
97.84M 72.06M 47.85M 26.83M
Other Working Capital
55.51M 7.71M -85.9M 54.8M
Other Non-Cash Items
50.6M 24.86M 60.48M 32.38M
Deferred Income Tax
n/a n/a n/a 2.84M
Change in Working Capital
35.66M 3.09M -24.7M 8.46M
Operating Cash Flow
-395.89M -414.33M -299.52M -142.52M
Capital Expenditures
-3.91M -1.42M -11.34M -48.87M
Cash Acquisitions
n/a n/a 250.8M 98.91M
Purchase of Investments
-1.29B -635.21M -855.39M -525.04M
Sales Maturities Of Investments
744.23M 875.88M 604.59M 426.14M
Other Investing Acitivies
n/a n/a -250.8M -98.91M
Investing Cash Flow
-553.1M 239.25M -262.13M -147.78M
Debt Repayment
-9.62M -858K 334.66M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
233.38M 57.94M 163.96M 7.93M
Financial Cash Flow
930.61M 221.32M 516.17M 319.98M
Net Cash Flow
-18.17M 46.22M -45.48M 29.68M
Free Cash Flow
-399.8M -415.75M -310.85M -191.39M